SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-21-000947
Filing Date
2021-04-14
Accepted
2021-04-14 16:19:08
Documents
55
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2243179z20-f.htm 20-F 1509271
2 EX-1.1 a2243179zex-1_1.htm EX-1.1 1950118
3 EX-8.1 a2243179zex-8_1.htm EX-8.1 7717
4 EX-12.1 a2243179zex-12_1.htm EX-12.1 10289
5 EX-12.2 a2243179zex-12_2.htm EX-12.2 10289
6 EX-13.1 a2243179zex-13_1.htm EX-13.1 5498
7 EX-15.1 a2243179zex-15_1.htm EX-15.1 2404
  Complete submission text file 0001047469-21-000947.txt   8736932

Data Files

Seq Description Document Type Size
8 EX-101.INS fwp-20201231.xml EX-101.INS 1661318
9 EX-101.SCH fwp-20201231.xsd EX-101.SCH 48661
10 EX-101.CAL fwp-20201231_cal.xml EX-101.CAL 42862
11 EX-101.DEF fwp-20201231_def.xml EX-101.DEF 154586
12 EX-101.LAB fwp-20201231_lab.xml EX-101.LAB 396174
13 EX-101.PRE fwp-20201231_pre.xml EX-101.PRE 280394
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 21825907
SIC: 2834 Pharmaceutical Preparations